Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types
Wencheng Zhang, Zhouyong Gao, Mingxiu Guan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis
Leiming Wang, Xi Yang, Fei Zhou, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7197-7208
Open Access | Times Cited: 33
ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
Mengyuan Zhao, Junchang Zhang, Yanjun He, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer
Chuanzhi Chen, Haili Bao, Lin Wu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 6, pp. 1985-2000
Open Access | Times Cited: 16
The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update
Li-Jun Yan, Andy T. Y. Lau, Yan‐Ming Xu
Epigenomics (2024) Vol. 16, Iss. 8, pp. 571-587
Closed Access | Times Cited: 2
Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA
Liya Huang, Ting Ye, Jingjing Wang, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 8
The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma
Zifa Zhang, Shuming Liu
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1111-1122
Open Access | Times Cited: 4
ASF1B is an essential prognostic indicator linked to the growth and resistance characteristics of bladder cancer
Peng Zhang, Peng Wang, Yirong Wang
Tissue and Cell (2024) Vol. 89, pp. 102477-102477
Closed Access | Times Cited: 1
The circCDK17/miR-122-5p/ASF1B axis regulates the progression of cervical cancer.
Fang Qiu, Dafen Ou, Hanxing Tan, et al.
PubMed (2023) Vol. 38, Iss. 3, pp. 359-371
Closed Access | Times Cited: 3
Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
Huaxin Zhu, Hengyang Ouyang, Xinyi Pan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
miR-24-3p Regulates Epithelial–Mesenchymal Transition and the Malignant Phenotype of Pancreatic Adenocarcinoma by Regulating ASF1B Expression
Wentao Huang, Tian-Sheng Lin, Long Huang, et al.
Biochemical Genetics (2022) Vol. 61, Iss. 2, pp. 742-761
Open Access | Times Cited: 5
Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers
Yiyang Chen, Wanbang Zhou, Yiju Gong, et al.
Gastroenterology Review (2023) Vol. 18, Iss. 3, pp. 249-265
Open Access | Times Cited: 2
Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD
Chuanzhi Chen, Yi Chen, Xin Jin, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
Comparative Review on Cancer Pathology from Aberrant Histone Chaperone Activity
J. Tsz Yan Lee, Xiucong Bao
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6403-6403
Open Access
Histone Chaperones in Cancer
Mayur Balkrishna Shirude, Debasree Dutta
(2024), pp. 845-864
Closed Access
Molecular Subtypes Defined by Cuproptosis-Associated Genes, Prognostic Model Development, and Tumor Immune Microenvironment Characterization in Adrenocortical Carcinoma
Qi Huang, Xu‐Yun Huang, Yu‐Ting Xue, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 7017-7036
Open Access
Transcriptomic analysis identified novel biomarker in invasive placenta accreta spectrum
Xiaoming Shi, Ling Jin, Xinlu Meng, et al.
Placenta (2024) Vol. 158, pp. 301-309
Closed Access
Predicting Prognostic Bidirectional Molecular Signatures Associating Myocardial Infarction and Lung Cancer: An In-Silico Perspective
Dhruva Nandi, Rajiv Janardhanan, Piyush Agrawal
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Multiple Myeloma: Genetic and Epigenetic Biomarkers with Clinical Potential
Yu. A. Veryaskina, С. Е. Титов, Н. В. Скворцова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13404-13404
Open Access
A PTEN-Autophagy Risk Model for the Prediction of Prognosis and Immune Microenvironment in Hepatocellular Carcinoma
Fei Huang, Dilinaer Yaermaimaiti, Guanxin Ding, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 1
CIA‐II is associated with lower‐grade glioma survival and cell proliferation
Feng Xiao, Hong Zhu, Yun Guo, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 1
Carcinogenic Role and Clinical Significance of Histone H3-H4 Chaperone Anti-silencing Function 1 B (ASF1B) in Lung Adenocarcinoma
Congkuan Song, Yaolin Song, Xiaoxia Wan, et al.
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 218-231
Open Access | Times Cited: 1
Screening a novel six critical gene-based system of diagnostic and prognostic biomarkers in prostate adenocarcinoma patients with different clinical variables.
Hadia Munir, Fawad Ahmad, Sajid Ullah, et al.
PubMed (2022) Vol. 14, Iss. 6, pp. 3658-3682
Closed Access | Times Cited: 2
miR-767-3p suppresses melanoma progression by inhibiting ASF1B expression
Xian Shi, Xidan Xu, Nian Shi, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 627, pp. 60-67
Closed Access | Times Cited: 2
Histone Chaperones in Cancer
Mayur Balkrishna Shirude, Debasree Dutta
(2023), pp. 1-20
Closed Access
Page 1 - Next Page

Scroll to top